- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 49/16 - AntibodiesImmunoglobulinsFragments thereof
Patent holdings for IPC class A61K 49/16
Total number of patents in this class: 351
10-year publication summary
|
26
|
28
|
29
|
28
|
24
|
15
|
14
|
17
|
13
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Astellas Pharma Inc. | 1049 |
10 |
| F. Hoffmann-La Roche AG | 7881 |
8 |
| OBI Pharma, Inc. | 126 |
8 |
| Centre National de La Recherche Scientifique | 10802 |
7 |
| Commissariat à l'énergie atomique et aux energies alternatives | 10976 |
7 |
| Institut Pasteur | 795 |
7 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2943 |
6 |
| Purdue Research Foundation | 3780 |
5 |
| Annexon, Inc. | 80 |
5 |
| Georgia State University Research Foundation, Inc. | 352 |
5 |
| University of Southern California | 2126 |
4 |
| Biogen International Neuroscience GmbH | 26 |
4 |
| On Target Laboratories, LLC | 32 |
4 |
| University of Tennessee Research Foundation | 753 |
4 |
| Bioverativ USA Inc. | 42 |
4 |
| Universite de Caen Normandie | 123 |
4 |
| Centre hospitalier universitaire de Caen Normandie | 9 |
4 |
| Abdera Therapeutics Inc. | 24 |
4 |
| Genentech, Inc. | 4038 |
3 |
| Janssen Pharmaceutica N.V. | 3322 |
3 |
| Other owners | 245 |